These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20021455)

  • 41. The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1.
    Ou YH; Chung PH; Hsu FF; Sun TP; Chang WY; Shieh SY
    EMBO J; 2007 Sep; 26(17):3968-80. PubMed ID: 17690688
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of novel target genes specifically activated by deregulated E2F in human normal fibroblasts.
    Kitamura H; Ozono E; Iwanaga R; Bradford AP; Okuno J; Shimizu E; Kurayoshi K; Kugawa K; Toh H; Ohtani K
    Genes Cells; 2015 Sep; 20(9):739-57. PubMed ID: 26201719
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polycomb protein EZH2 regulates E2F1-dependent apoptosis through epigenetically modulating Bim expression.
    Wu ZL; Zheng SS; Li ZM; Qiao YY; Aau MY; Yu Q
    Cell Death Differ; 2010 May; 17(5):801-10. PubMed ID: 19893569
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mdm2 inhibition of p53 induces E2F1 transactivation via p21.
    Wunderlich M; Berberich SJ
    Oncogene; 2002 Jun; 21(28):4414-21. PubMed ID: 12080472
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The E2F1-miRNA cancer progression network.
    Knoll S; Emmrich S; Pützer BM
    Adv Exp Med Biol; 2013; 774():135-47. PubMed ID: 23377972
    [TBL] [Abstract][Full Text] [Related]  

  • 46. E2F-1 is a critical modulator of cellular senescence in human cancer.
    Park C; Lee I; Kang WK
    Int J Mol Med; 2006 May; 17(5):715-20. PubMed ID: 16596252
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The long non-coding RNA ERIC is regulated by E2F and modulates the cellular response to DNA damage.
    Feldstein O; Nizri T; Doniger T; Jacob J; Rechavi G; Ginsberg D
    Mol Cancer; 2013 Oct; 12(1):131. PubMed ID: 24168400
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lysine methylation regulates E2F1-induced cell death.
    Kontaki H; Talianidis I
    Mol Cell; 2010 Jul; 39(1):152-60. PubMed ID: 20603083
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular pathways: harnessing E2F1 regulation for prosenescence therapy in p53-defective cancer cells.
    Laine A; Westermarck J
    Clin Cancer Res; 2014 Jul; 20(14):3644-50. PubMed ID: 24788101
    [TBL] [Abstract][Full Text] [Related]  

  • 50. RBM38 is a direct transcriptional target of E2F1 that limits E2F1-induced proliferation.
    Feldstein O; Ben-Hamo R; Bashari D; Efroni S; Ginsberg D
    Mol Cancer Res; 2012 Sep; 10(9):1169-77. PubMed ID: 22798430
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Deregulated E2F Activity as a Cancer-Cell Specific Therapeutic Tool.
    Nakajima R; Zhao L; Zhou Y; Shirasawa M; Uchida A; Murakawa H; Fikriyanti M; Iwanaga R; Bradford AP; Araki K; Warita T; Ohtani K
    Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833320
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Estrogen-activated MDM2 disrupts mammary tissue architecture through a p53-independent pathway.
    Kundu N; Brekman A; Kim JY; Xiao G; Gao C; Bargonetti J
    Oncotarget; 2017 Jul; 8(29):47916-47930. PubMed ID: 28615518
    [TBL] [Abstract][Full Text] [Related]  

  • 53. E2F1 activates p53 transcription through its distal site and participates in apoptosis induction in HPV-positive cells.
    Massip A; Arcondéguy T; Touriol C; Basset C; Prats H; Lacazette E
    FEBS Lett; 2013 Oct; 587(19):3188-94. PubMed ID: 23954287
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation.
    Lee KH; Chen YL; Yeh SD; Hsiao M; Lin JT; Goan YG; Lu PJ
    Oncogene; 2009 Sep; 28(38):3360-70. PubMed ID: 19597470
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The cellular effects of E2F overexpression.
    Adams PD; Kaelin WG
    Curr Top Microbiol Immunol; 1996; 208():79-93. PubMed ID: 8575214
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gene therapy for gliomas: p53 and E2F-1 proteins and the target of apoptosis.
    Gomez-Manzano C; Fueyo J; Alameda F; Kyritsis AP; Yung WK
    Int J Mol Med; 1999 Jan; 3(1):81-5. PubMed ID: 9864390
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epigenetic factor EPC1 is a master regulator of DNA damage response by interacting with E2F1 to silence death and activate metastasis-related gene signatures.
    Wang Y; Alla V; Goody D; Gupta SK; Spitschak A; Wolkenhauer O; Pützer BM; Engelmann D
    Nucleic Acids Res; 2016 Jan; 44(1):117-33. PubMed ID: 26350215
    [TBL] [Abstract][Full Text] [Related]  

  • 58. E2F1 plays a direct role in Rb stabilization and p53-independent tumor suppression.
    Palacios G; Talos F; Nemajerova A; Moll UM; Petrenko O
    Cell Cycle; 2008 Jun; 7(12):1776-81. PubMed ID: 18583939
    [TBL] [Abstract][Full Text] [Related]  

  • 59. RB-E2F1: molecular rheostat for autophagy and apoptosis.
    Jiang H; Martin V; Alonso M; Gomez-Manzano C; Fueyo J
    Autophagy; 2010 Nov; 6(8):1216-7. PubMed ID: 20935482
    [No Abstract]   [Full Text] [Related]  

  • 60. The conflicting role of E2F1 in prostate cancer: A matter of cell context or interpretational flexibility?
    Chun JN; Cho M; Park S; So I; Jeon JH
    Biochim Biophys Acta Rev Cancer; 2020 Jan; 1873(1):188336. PubMed ID: 31870703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.